L3MBTL3 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-47315APC
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot (Negative)
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for L3MBTL3 Antibody [Allophycocyanin]
Immunogen
The immunogen for this product maps to a region between residue 100 and 150 of human Lethal(3)Malignant Brain Tumor-like 3 using the numbering given in entry NP_115814.1 (GeneID 84456).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for L3MBTL3 Antibody [Allophycocyanin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: L3MBTL3
Long Name
L3MBTL Histone Methyl-Lysine Binding Protein 3
Alternate Names
KIAA1798, MBT-1
Gene Symbol
L3MBTL3
Additional L3MBTL3 Products
Product Documents for L3MBTL3 Antibody [Allophycocyanin]
Product Specific Notices for L3MBTL3 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...